Eli Lilly and NVIDIA to Build Pharma Supercomputer

Plus: Nvidia unveils a new product that merges AI supercomputing with quantum. And the AI giant partners with Eli Lilly to build a supercomputer that could boost drug discovery. Julie Chang hosts.

Correction: OpenAI’s nonprofit parent owns a stake in its for-profit subsidiary, which has become a public-benefit corporation. An earlier version of this podcast incorrectly said OpenAI had become a for-profit company. (Corrected Oct. 28)

Learn more about your ad choices. Visit megaphone.fm/adchoices